Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
Submitted by
admin
on October 24, 2021 - 10:32pm
Source:
Motley Fool
News Tags:
Merck
antivirals
COVID-19
Gilead Sciences
Headline:
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
snippet:
Merck is developing an oral antiviral medication against COVID-19.
For hospitals, antiviral pills are far easier to administer than antiviral IV infusions.
Avoid rushing to invest based on early information as things may change later.
Do Not Allow Advertisers to Use My Personal information
